Biotech News
-
Voyageur Pharmaceuticals Ltd., Announces The Creation of a New Scientific Advisory Board With World Class Leading Physicians
September 14, 2021 (Source) — Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) (the “Company” or “Voyageur”) develops, manufactures and will commercialize high-performance…
-
DIAGNOS Announces a 3-Year Contract with Cielo Vista Eye Clinic in Mexico
September 14, 2021 (Source) — Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a…
-
Element Nutritional Sciences Forms Medical Advisory Board
September 14, 2021 (Source) — Medical Advisory Board to formalize and accelerate development of higher dosage Rejuvenate™ formulations…
-
Hemostemix Announces the First of a Series of 2021 Video Interviews with ACP-01 Recipients: What the Successful Compassionate Treatment of Ischemic Cardiomyopathy Looks Like After 13 Years
September 14, 2021 (Source) — Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (“Hemostemix” or the “Company”) is pleased to…
-
DIAGNOS Announces Voting Results of Annual Meeting of Shareholders
September 10, 2021 (Source) — Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB:DGNOF), a leader in…
-
Rritual Superfoods Announces Closing of Bought Deal
September 10, 2021 (Source) — NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE U.S.…
-
Awakn Life Sciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 9, 2021 (Source) — Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a biotechnology company…
-
Hemostemix Announces Five Million Unit Private Placement
September 8, 2021 (Source) — Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (“Hemostemix” or the “Company”) is pleased to announce…
-
Sixth Wave Innovations Inc. and Mining and Process Solutions Complete Phase 1 “Green Lixiviant” Testing for Gold Mining with Outstanding Results
September 8, 2021 (Source) — Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (the “Company” or “Sixth…
-
XPhyto Reports Successful Market Launch and Growing Demand for its 25-minute COVID-19 PCR Test COVID-ID Lab
September 8, 2021 (Source) — XPhyto Therapeutics Corp. (CSE:XPHY) (OTCQB:XPHYF) (FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce the…
